Using the ROC analysis the cut-off level of the SNA/anti-IgM index that allows the best discrimination of cancer patients with high SNA binding and low anti-TF IgM level from controls was determined to be equal to 6.1 (cut-off 1). This evidence concerns the gene CD40LG and cancer.